InvestorsHub Logo

axelvento

10/10/17 3:52 PM

#130 RE: ice1234 #129

BIG NEWS IMMINENT............"We believe CERC-611 has the potential to provide a true advancement in epilepsy therapy," said Uli Hacksell Ph.D., Cerecor's CEO, President and Chairman. "We anticipate filing an investigational new drug application with the United States Food and Drug Administration and thereafter commence Phase 1 development of CERC-611 in 2017."


http://ir.cerecor.com/press-releases/detail/28/discovery-of-cerecor-drug-candidate-cerc-611-ly3130481